Aisling (Zhangjiagang) Technology Co., Ltd. was established in 2023 and is an innovative high-tech enterprise with biochemical synthesis and detection technology as its core. The company focuses on the research and development, production, and sales of high-end synthetic and detection reagents, exploring and carrying out interdisciplinary cutting-edge scientific research results.

The company has a wide range of product categories, focusing on research, technological development and production in the field of biochemistry, pharmaceutical process development and production, as well as analysis and testing scenarios in multiple industries. We can provide customized, high-quality, and stable solutions and services tailored to the needs of different customers.

SynStar, a subsidiary brand, focuses on the field of oligonucleotide drug synthesis. Our technical partners have been deeply involved in this field for nearly 10 years, independently developing and producing a series of oligonucleotide drug synthesis raw materials with unique formulas and excellent quality, providing customers with efficient and reliable supply options.